Precision Biosciences Inc’s recent filing unveils that its Director Germano Geno J acquired Company’s shares for reported $16186.0 on Dec 30 ’24. In the deal valued at $4.49 per share,3,605 shares were bought. As a result of this transaction, Germano Geno J now holds 7,807 shares worth roughly $38722.72.
Then, Buehler Kevin bought 4,320 shares, generating $21,082 in total proceeds. Upon buying the shares at $4.88, the Director now owns 8,712 shares.
Before that, Kelly John Alexander bought 2,113 shares. Precision Biosciences Inc shares valued at $10,037 were divested by the Chief Financial Officer at a price of $4.75 per share. As a result of the transaction, Kelly John Alexander now holds 40,186 shares, worth roughly $0.2 million.
BMO Capital Markets upgraded its Precision Biosciences Inc [DTIL] rating to an Outperform from a a Market perform in a research note published recently. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in late April with a ‘”a Buy”‘ rating. BMO Capital Markets began covering DTIL with “an Outperform” recommendation on June 17, 2022. William Blair revised its rating on June 09, 2022. It rated DTIL as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of DTIL
On Friday, Precision Biosciences Inc [NASDAQ:DTIL] saw its stock jump 5.08% to $4.96. Over the last five days, the stock has lost -12.98%. Precision Biosciences Inc shares have risen nearly 30.18% since the year began. Nevertheless, the stocks have fallen -57.61% over the past one year. While a 52-week high of $19.43 was reached on 01/10/25, a 52-week low of $3.61 was recorded on 01/02/25. SMA at 50 days reached $6.04, while 200 days put it at $9.26.
Levels Of Support And Resistance For DTIL Stock
The 24-hour chart illustrates a support level at 4.71, which if violated will result in even more drops to 4.47. On the upside, there is a resistance level at 5.13. A further resistance level may holdings at 5.30. The Relative Strength Index (RSI) on the 14-day chart is 46.54, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.13, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 64.75%. Stochastics %K at 35.77% indicates the stock is a holding.
How much short interest is there in Precision Biosciences Inc?
A steep rise in short interest was recorded in Precision Biosciences Inc stocks on 2024-12-31, growing by 37177.0 shares to a total of 0.31 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 0.27 million shares. There was a rise of 12.12%, which implies that there is a positive sentiment for the stock.
